Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion:: a pilot study

被引：35

作者：

Krepler, K ^{[1
]}

Ergun, E ^{[1
]}

Sacu, S ^{[1
]}

Richter-Müksch, S ^{[1
]}

Wagner, J ^{[1
]}

Stur, M ^{[1
]}

Wedrich, A ^{[1
]}

机构：

[1] Med Univ Vienna, Dept Ophthalmol, A-1090 Vienna, Austria

来源：

ACTA OPHTHALMOLOGICA SCANDINAVICA | 2005年 / 83卷 / 05期

关键词：

macular oedema; branch retinal vein occlusion; triamcinolone; intravitreal; NONINFECTIOUS ENDOPHTHALMITIS; INJECTION;

D O I：

10.1111/j.1600-0420.2005.00490.x

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Purpose: To evaluate treatment of macular oedema due to branch retinal vein occlusion (BRVO) with intravitreal triamcinolone acetonide. Methods: In a prospective case series, nine patients with macular oedema due to BRVO received an intravitreal injection of 4 mg triamcinolone acetonide. Examination included best-corrected visual acuity (BCVA) for distance and reading, intraocular pressure (IOP) measurement, fluorescein angiography and high resolution imaging by optical coherence tomography, preoperatively and at 1 week, 1 month, 3 and 6 months postoperatively. Results: Preoperative mean BCVAs were 1.3 +/- 0.8 for distance vision, and 1.1 +/- 0.3 for reading acuity, respectively. A significant improvement in reading acuity was observed until 1 month (0.7 +/- 0.4, p = 0.02). No significant reduction in mean macular thickness was observed. Conclusions: Intravitreal injection of triamcinolone acetonide led to a significant improvement in mean VA in patients with macular oedema due to BRVO. However, the significant effect was not permanent and persisted for only 1 month.

引用

页码：600 / 604

页数：5

共 50 条

[41] Comparison of intravitreal injection of conbercept and triamcinolone acetonide for macular edema secondary to branch retinal vein occlusion
Miao Zhao
Ce Zhang
Xi-Mei Chen
Yan Teng
Tian-Wei Shi
Fei Liu
International Journal of Ophthalmology, 2020, (11) : 1765 - 1772
[42] Intravitreal Triamcinolone Acetonide versus Bevacizumab Therapy for Macular Edema Associated With Branch Retinal Vein Occlusion
Byun, Y. J.
Koh, H. J.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
[43] Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion
Jonas, JB
Kreissig, I
Degenring, RF
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2002, 240 (09) : 782 - 783
[44] Sir, Reply to intravitreal triamcinolone acetonide as treatment of branch retinal vein occlusion
Jonas, J. B.
Akkoyun, I.
Kamppeter, B.
Kreissig, I.
Degenring, R. F.
EYE, 2006, 20 (06) : 728 - 728
[45] Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion
Jost B. Jonas
Ingrid Kreissig
Robert F. Degenring
Graefe’s Archive for Clinical and Experimental Ophthalmology, 2002, 240 : 782 - 783
[46] Retinal sensitivity improvement after intravitreal triamcinolone acetonide injection for macular edema secondary to branch retinal vein occlusion
Senturk, Fevzi
Ozdemir, Hakan
Karacorlu, Murat
Karacorlu, Serra Arf
Uysal, Omer
INDIAN JOURNAL OF OPHTHALMOLOGY, 2013, 61 (01) : 3 - 7
[47] Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion
Guenduez, K.
Bakri, S. J.
EYE, 2008, 22 (09) : 1168 - 1171
[48] Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion
K Gündüz
S J Bakri
Eye, 2008, 22 : 1168 - 1171
[49] Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion
J Moon
M Kim
M Sagong
Eye, 2016, 30 : 1084 - 1090
[50] Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion
Moon, J.
Kim, M.
Sagong, M.
EYE, 2016, 30 (08) : 1084 - 1090

← 1 2 3 4 5 →